2010-04-02
The
Centers for Disease Control and Prevention (CDC) announced a new grant program,
Population Based Surveillance for Deep-Vein Thrombosis (DVT)
and Pulmonary Embolism (PE) (CDC-RFA-DD10-1016).
The application due date is May 11, 2010. The purpose of the program
is to develop and evaluate pilot programs for population-based surveillance of
deep-vein thrombosis (DVT) and pulmonary embolism (PE). Given the complexity of
diagnosis and care of DVT and PE, the CDC is evaluating models and methods to
effectively and validly estimate the public health burden of DVT and PE in the
United States.
The pilot programs will serve to
not only guide future DVT and PE surveillance activities, but also to aid in
the CDC’s comprehensive public health approach to preventing morbidity and mortality
and reducing burden from DVT and PE. Surveillance of DVT and PE will help the
CDC better understand where to focus research and target prevention measures
while also providing a much-needed baseline upon which to assess the
effectiveness of prevention efforts.
ASH has worked closely with the CDC to develop a national DVT and PE
surveillance program and is pleased to see the grant announcement. Read ASH’s
recently published recommendations on surveillance for DVT and PE in the March Supplement
to the American Journal of Preventive Medicine (AJPM): Blood Disorders in Public Health – Making the Connection.
back to top
